Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Health Care Supplies

Nuo Therapeutics Inc

+ Add to Watchlist

4C7A:GR

0.270 EUR 0.0000.00%

As of 02:06:29 ET on 01/30/2015.

Snapshot for Nuo Therapeutics Inc (4C7A)

Open: 0.270 Day's Range: 0.270 - 0.270 Volume: 0
Previous Close: 0.270 52wk Range: 0.210 - 0.456 1-Yr Rtn: -36.02%

Stock Chart for 4C7A

No chart data available.
  • 4C7A:GR 0.270
  • 1M
  • 1Y
0.270
Interactive 4C7A Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 4C7A

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. DAX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M EUR) 33.59
Shares Outstanding (M) 124.41
30 Day Average Volume 533
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/31/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 4C7A

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for 4C7A

Nuo Therapeutics Inc is a global biotechnology company focused on developing and commercializing cellular therapies that serve unmet clinical needs. The Company markets the Autogel process and Procuren, autologous wound healing therapies with multiple growth factors designed to initiate the body's natural healing process.

David E JordenChairmanMartin P RosendaleChief Executive Officer
Dean Tozer Chief Commercial OfficerPeter ClausenChief Science Officer
More Company Profile & Key Executives for 4C7A

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil